Strategic Treatment Optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

Cooke GS., Pett S., McCabe L., Jones C., Gilson R., Verma S., Ryder SD., Collier JD., Barclay ST., Ala A., Bhagani S., Nelson M., Ch’Ng C., Stone B., Wiselka M., Forton D., McPherson S., Halford R., Nguyen D., Smith D., Ansari A., Dennis E., Hudson F., Barnes EJ., Walker AS.

DOI

10.1101/2021.01.22.21250208

Type

Preprint

Publication Date

26/01/2021

Permalink Original publication